| [1] |
|
| [2] |
Mona C, Meryam M, Nizar K, et al. Exploring rare locations of hydatid disease: a retrospective case series[J]. BMC Surg, 2024, 24(1): 160.DOI: 10.1186/s12893-024-02443-x.
|
| [3] |
Manterola C, Rivadeneira J, Rojas C, et al. Prevalence of cystic echinococcosis in relatives of patients undergoing surgery for hepatic cystic echinococcosis in an endemic region[J]. PLoS Negl Trop Dis, 2023, 17(12): e0011813.DOI: 10.1371/journal.pntd.0011813.
|
| [4] |
Fan SH, Li N, Huang KF, et al. MyoD over-expression rescues GST-bFGF repressed myogenesis[J]. Int J Mol Sci, 2024, 25(8): 4308.DOI: 10.3390/ijms25084308.
|
| [5] |
Gao F, Mu W, Fan J, et al. β-arrestin2 promotes angiogenesis of liver sinusoidal endothelial cells through the VEGF/VEGFR2 pathway to aggravate cirrhosis[J]. Toxicol Lett, 2024, 401: 1-12.DOI: 10.1016/j.toxlet.2024.08.011.
|
| [6] |
Liu X, Wang X, Xu L, et al. Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathways[J]. Eur J Pharmacol, 2024, 977: 176708.DOI: 10.1016/j.ejphar.2024.176708.
|
| [7] |
|
| [8] |
|
| [9] |
Abdoli N, Sadeghian I, Azarpira N, et al. Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters[J]. Clin Exp Hepatol, 2021, 7(1): 30-40.DOI: 10.5114/ceh.2021.104675.
|
| [10] |
Wang H, Yu Q, Wang M, et al. Hepatic macrophages play critical roles in the establishment and growth of hydatid cysts in the liver during Echinococcus granulosus sensu stricto infection[J]. PLoS Negl Trop Dis, 2023, 17(11): e0011746.DOI: 10.1371/journal.pntd.0011746.
|
| [11] |
Tian F, Liu Y, Gao J, et al. Study on the association between TGF-β1 and liver fibrosis in patients with hepatic cystic echinococcosis[J]. Exp Ther Med, 2020, 19(2): 1275-1280.DOI: 10.3892/etm.2019.8355.
|
| [12] |
|
| [13] |
|
| [14] |
Labsi M, Soufli I, Amir ZC, et al. Hepatic inflammation and liver fibrogenesis: a potential target for the treatment of cystic echinococcosis-associated hepatic injury[J]. Acta Trop, 2022, 226: 106265.DOI: 10.1016/j.actatropica.2021.106265.
|
| [15] |
Yang N, Ma W, Ke Y, et al. Transplantation of adipose-derived stem cells ameliorates Echinococcus multilocularis-induced liver fibrosis in mice[J]. PLoS Negl Trop Dis, 2022, 16(1): e0010175.DOI: 10.1371/journal.pntd.0010175.
|
| [16] |
Breitkopf-Heinlein K, Martinez-Chantar ML. Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?[J]. Gut, 2024, 73(9): 1411-1413.DOI: 10.1136/gutjnl-2023-331785.
|
| [17] |
Wada T, Takeda Y, Okekawa A, et al. Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes[J]. Sci Rep, 2024, 14(1): 23829.DOI: 10.1038/s41598-024-75713-6.
|
| [18] |
Amansyah F, Budu B, Achmad MH, et al. Secretome of hypoxia-preconditioned mesenchymal stem cells promotes liver regeneration and anti-fibrotic effect in liver fibrosis animal model[J]. Pak J Biol Sci, 2024, 27(1): 18-26.DOI: 10.3923/pjbs.2024.18.26.
|
| [19] |
Xu XY, Geng Y, Xu HX, et al. Antrodia camphorata-derived antrodin C inhibits liver fibrosis by blocking TGF-beta and PDGF signaling pathways[J]. Front Mol Biosci, 2022, 9: 835508.DOI: 10.3389/fmolb.2022.835508.
|
| [20] |
Meng Q, Luo L, Lei M, et al. Inhibition of FGFR2 signaling by cynaroside attenuates liver fibrosis[J]. Pharmaceuticals, 2023, 16(4): 548.DOI: 10.3390/ph16040548.
|
| [21] |
Cheng YS, Taniguchi Y, Yunoki Y, et al. Simultaneous binding of bFGF to both FGFR and integrin maintains properties of primed human induced pluripotent stem cells[J]. Regen Ther, 2023, 25: 113-127.DOI: 10.1016/j.reth.2023.12.008.
|
| [22] |
Shi Q, Wei S, Li ZC, et al. Collagen-binding fibroblast growth factor ameliorates liver fibrosis in murine bile duct ligation injury[J]. J Biomater Appl, 2022, 37(5): 918-929.DOI: 10.1177/08853282221121861.
|
| [23] |
Radosavljevic T, Vukicevic D, Djuretić J, et al. The role of macrophage inhibitory factor in TAA-induced liver fibrosis in mice: modulatory effects of betaine[J]. Biomedicines, 2024, 12(6): 1337.DOI: 10.3390/biomedicines12061337.
|
| [24] |
Jin J, Yang H, Hu L, et al. Inonotsuoxide B suppresses hepatic stellate cell activation and proliferation via the PI3K/AKT and ERK1/2 pathway[J]. Exp Ther Med, 2022, 23(6): 417.DOI: 10.3892/etm.2022.11344.
|
| [25] |
Ying HZ, Chen Q, Zhang WY, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)[J]. Mol Med Rep, 2017, 16(6): 7879-7889.DOI: 10.3892/mmr.2017.7641.
|